Shares of Merck & Co. Inc. MRK slipped 0.03% to $99.14 Friday, on what proved to be an all-around great trading session for ...

Shares of Merck & Co. Inc. MRK slumped 0.31% to $99.17 Thursday, on what proved to be an all-around dismal trading session ...

We recently published a list of 8 Best Low Volatility Stocks To Buy Right Now. In this article, we are going to take a look ...

Li, executive vice president and president, Merck Research Laboratories, are scheduled to participate in a fireside chat at ...

China's WuXi Biologics said on Monday it will sell its vaccine facility in Ireland to Merck for about $500 million. WuXi had ...

Non-transplant salvage therapy for low-risk relapsed/refractory pediatric classical Hodgkin lymphoma (cHL) had high rates of ...

We recently compiled a list of the 13 Best Pharma Dividend Stocks To Buy In 2024. In this article, we are going to take a ...

Merck & Co.’s Covid-19 antivirals are getting a new lease of life in post-pandemic China, as cat owners seize on them as ...

The startup is developing a kind of macrocyles, which share strengths of both small molecules and biologics, to make oral ...

PD-1 x VEGF antibodies show potential to surpass checkpoint inhibitors as standard-of-care in multiple oncology indications• NAYA aiming to ...

BMO Capital Markets has recently reduced Merck & Co Inc (MRK) stock to Market Perform rating, as announced on December 20, 2024, according to Finviz. Earlier, on December 10, 2024, BofA Securities had ...

Moderna/Merck partnership and its potential in personalised cancer therapies are good opportunities for long-term investors.